2025 ACVR Banner with theme

Call for Abstracts Now Open

The National Foundation for Infectious Diseases (NFID) invites abstract submissions of original research in the field of vaccinology. Abstracts are peer-reviewed for quality of research, educational, and scientific content. Accepted abstracts will be scheduled as either poster or oral presentations. Notifications will be sent in March 2025.

The Maurice R. Hilleman Early-Stage Career Investigator Award recognizes individuals in the early stages of their career in any field of vaccinology. The awardee will be recognized during the 2025 conference. To apply for award consideration, applicants must submit an abstract under the “Poster Abstract Only-Hilleman Award” submission type.

Submission Deadline: February 12, 2025

Please note that the NFID does not provide travel assistance, stipends, or reimbursements for individuals with accepted abstracts. All expenses related to travel, lodging, and participation in the conference are the responsibility of the individual.

About the Conference

The Annual Conference on Vaccinology Research brings together the diverse disciplines involved in vaccine research, development, implementation, and real-world evaluation. By drawing upon an international audience of scientists and researchers, healthcare professionals, manufacturers, and public health officials, the conference is designed to facilitate the exchange of ideas across a broad range of disciplines, addressing challenges and breakthroughs in vaccinology.

For more than 25 years, the annual conference has been well-regarded by attendees as a forum for relevant discussions and collaborations across the breadth of vaccinology.

Questions? Email: [email protected]

Continuing Education and Learning Objectives

ACVR Posters

Overall Conference Learning Objectives

At the conclusion of this activity, participants will be able to:

    • Discuss recent scientific advances contributing to vaccine research, development, implementation, and real-world evaluation
    • Identify novel research opportunities and scientific challenges associated with vaccine development, implementation, and real-world evaluation
    • Evaluate the role of immunization in preventing and mitigating existing, emerging, and re-emerging infectious diseases

 

Planning Committee

Kimberley Fox, MD, MPH

Kimberley Fox, MD, MPH

Bruce G. Gellin, MD, MPH

Portrait of Hana Golding

Hana Golding, PhD

Robert H. Hopkins, Jr., MD

Robert H. Hopkins, Jr., MD

NFID Director Flor M. Muñoz, MD, MSc receives an influenza vaccination at 2024 NFID Annual News Conference

Flor M. Muñoz, MD, MSc

Seema U. Nayak, MD

Kathleen M. Neuzil Getting Vaccinated

Kathleen M. Neuzil, MD, MPH

Ousseny Zerbo, PhD